Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression

6Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Lymphoplasmacyte-rich meningioma (LPRM) is one of the rarest variants of grade I meningiomas. It can be clinically associated with prominent peripheral blood abnormalities, anemia, and/or various gammopathy, which usually disappear after surgical removal of the tumor. We document a case of right frontal LPRM in a 72-year-old male who presented general cognitive decadence. The patient suffered from mild anemia. The LPRM is a rare variant of meningioma, with only a few cases globally reported in the literature. It has been categorized as a grade I tumor in the 2021 World Health Organization (WHO) classification central nervous system. Due to the rarity, this meningioma variant origin and biological behavior are still not clear. Immunohistochemistry profile showed prominent PD-L1 expression, leading to additional interrogation on LPRM immunomorphological characteristics, the significance of the inflammatory tumoral microenvironment and its correlation with the immune-checkpoints.

Author supplied keywords

Cite

CITATION STYLE

APA

Gaggero, G., Campora, M., Taietti, D., Cerruti, G., Lo Bue, E., Truffelli, M., … Fiaschi, P. (2022). Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression. Autopsy and Case Reports, 12. https://doi.org/10.4322/ACR.2021.394

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free